Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
5
×
clinical trials
detroit blog main
detroit top stories
fda
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer immunotherapy
eli lilly
nivolumab
abbvie
alzheimer's disease
boehringer ingelheim
bristol-myers squibb
chronic kidney disease
drugs
gene therapy
What
week
5
×
bio
companies
life
roundup
science
ipo
rolls
therapeutics
alzheimer’s
american
annual
arena’s
ash
assessed
attention
big
biotech
biotechs
black
blood
bounty
cig
club
comeback
communities
conference
continue
continued
corner
country
crop
deals
debut
delivered
diamond
diamond’s
diego
disease
drug
Language
unset
Current search:
week
×
fda
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M